We are live on ! Find out more
APGN

Apexigen, Inc. Common Stock
APGN

Delisted

APGN was delisted on the 22nd of August, 2023.

Back to rankings

38 hedge funds and large institutions have $32.5M invested in Apexigen, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

29% more capital invested

Capital invested by funds: $25.3M → $32.5M (+$7.26M)

23% more funds holding

Funds holding: 31 → 38 (+7)

Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
+$2.99M
2
KIM
Karpus Investment Management
New York
+$1.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.06M
4
LA
Linden Advisors
New York
+$621K
5
Walleye Trading
Walleye Trading
New York
+$162K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$147K
2
MSU
Mizuho Securities USA
New York
-$126K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$115K
4
HI
Harbour Investments
Wisconsin
-$10.1K
5
PC
Periscope Capital
Ontario, Canada
-$1.99K
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
1
Periscope Capital
Ontario, Canada
$4.17M -$1.99K -200 -0%
KC
2
Kepos Capital
New York
$3.83M +$2.99M +300,000 +365%
KIM
3
Karpus Investment Management
New York
$3.64M +$1.2M +120,636 +50%
FTCM
4
Fir Tree Capital Management
New York
$3M – – –
BCM
5
Basso Capital Management
Connecticut
$2.81M – – –
Tudor Investment Corp
6
Tudor Investment Corp
Connecticut
$2M – – –
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$1.69M +$1.06M +106,317 +170%
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$1.4M – – –
RCM
9
Radcliffe Capital Management
Pennsylvania
$1.32M – – –
CH
10
CVI Holdings
Delaware
$1M – – –
RCM
11
Rivernorth Capital Management
Florida
$1M – – –
WRBC
12
W.R. Berkley Corp
Connecticut
$776K +$31.3K +3,140 +4%
Jane Street
13
Jane Street
New York
$765K +$7.57K +760 +1%
PAMP
14
Polar Asset Management Partners
Ontario, Canada
$757K – – –
LSC
15
Logan Stone Capital
Illinois
$675K +$672K +67,416 New
LA
16
Linden Advisors
New York
$624K +$621K +62,282 New
CM
17
Crestline Management
Texas
$410K – – –
WAM
18
Wolverine Asset Management
Illinois
$338K +$24.3K +2,437 +8%
Millennium Management
19
Millennium Management
New York
$332K -$147K -14,720 -31%
LCM
20
Landscape Capital Management
New Jersey
$328K – – –
WAM
21
Weiss Asset Management
Massachusetts
$291K +$28.7K +2,880 +11%
SSA
22
Schonfeld Strategic Advisors
New York
$229K +$72.9K +7,317 +47%
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$170K – – –
Walleye Trading
24
Walleye Trading
New York
$163K +$162K +16,268 New
Walleye Capital
25
Walleye Capital
New York
$146K +$145K +14,536 New
1
2

APGN Hedge Fund Activity: Q4 2021 in Review

38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q4 2021, worth a combined $32.5M — up 29% from $25.3M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new APGN positions and 2 closed out — a net gain of 8 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Kepos Capital, adding an estimated $2.99M. The largest seller was Millennium Management, cutting an estimated $147K.

  • 38 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q4 2021, up from 31 in Q3 2021.
  • Funds reported $32.5M of Apexigen, Inc. Common Stock stock for Q4 2021, up 29% quarter-over-quarter.
  • 10 funds opened new Apexigen, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +8 holders.
  • The largest Apexigen, Inc. Common Stock buyer in Q4 2021 was Kepos Capital, an estimated $2.99M added.
  • The largest Apexigen, Inc. Common Stock seller in Q4 2021 was Millennium Management, an estimated $147K sold.

Based on aggregated 13F filings for Q4 2021.